Other breast cancer studies showed that the abnormal DNA methylation of these gene families could be the consequence of the reduction of CTCF interaction with DNA due to CTCF aberrant expression or mutations in its binding domain [19, 20]. The gene discussed is CTCF; the disease is breast carcinoma.